A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC)
- Resource Type
- Short Communication
- Source
- In
Cancer Treatment and Research Communications 2021 28 - Subject
- Language
- ISSN
- 2468-2942